Diseases and disorders Books
John Wiley and Sons Ltd Obesity American Heart Association Monograph
Book SynopsisObesity is becoming increasingly prevalent in a worldwide context, and has been recognised as a major contributing factor in heart disease. This volume was authored by the participants in a 1998 AHA sponsored conference on the impact of obesity on cardiovascular disease. The three main sections of the book set out to evaluate current research pertaining to causation and cardiovascular sequela of obesity. Part I defines obesity, exploring its epidemiology, its genetic and non-genetic influences and its contribution to the problem of cardiovascular disease. Special attention is given to the primary prevention of obesity as a means of avoiding specific sequelae as well as the difficulties experienced by those who try to lose weight. Part II deals with the relatively new and much heralded discovery of obesity related genes the current state of diet drugs and valvular heart disease, and the interaction of obesity and metabolism, hormonal regulation and various other biological systems. RTrade Review"This is a superb and needed book."—American Journal of Cardiology "This book may best be considered an excellent update on obesity."—Texas Heart Institute Journal "Excellent Four Stars. A comprehensive review of an important clinical area in which treatment options are badly needed."—Mayo Clinic ProceedingsTable of ContentsContributors. Acknowledgement. Preface. (S.M. Grundy). Part 1: Epidemiology of Obesity. Chapter 1. Epidemiology of Obesity in Adults in Relationship to Cardiovascular Disease. (L.H. Kuller). Chapter 2. Obesity in Children, Adolescents and Families. (E. Obarzanek). Chapter 3. Developmental Aspects of Obesity: Genetic Influences. (T.L. Burns). Chapter 4. Developmental Aspects of Obesity: Nongenetic Influences. (L.L. Hayman). Chapter 5. Prevention of Obesity. (S.R. Daniels). Part 2: Pathophysiology of Disease. Chapter 6. Obesity Related Genes. (R.M. Krauss). Chapter 7. Diet Drugs and Valvular Heart DIsease. (G.P. Aurigemma). Chapter 8. Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension. (J.E. Hall, M.W. Brands, D.W. Jones, E.W. Shek, J. Henegar). Chapter 9. Obesity and Lipoprotein Metabolism: Relationship to Cardiovascular Disease. (B.V. Howard). Chapter 10. Is Insulin Resistance and Independent Risk Factor for Coronary Heart Disease? (S.M. Grundy). Chapter 11. Obesity and Postmenopausal Women. (K.M. Newton). Chapter 12. Late Breaking Advances in the Biological Understanding of Obesity and its Sequelae. (R.H. Eckel). Part 3: Assessment, Interventions, Treatment and Outcomes. Chapter 13. Body Composition Assessment: Epidemiological, Clinical and Research Tools. (M.E. Sweeney). Chapter 14. Dietary Strategies: Issues of Diet Composition. (S.T. St. Jeor, J.M. Ashley). Chapter 15. Energy Expenditure and Obesity. (J.O. Hill, Adamandia D. Kriketos). Chapter 16. Physical Activity in the Management of Obesity: Issues and Implementation. (M.L. Stefanick). Chapter 17. Efficacy and Safety of Pharmacological Interventions for the Overweight Patient. (G.A. Bray). Chapter 18. Behavioural Interaction. (J.P. Foreyt, W.S. Carlos Poston). Chapter 19. Strategies to Enhance Compliance to Weight-Loss Treatment. (L.E. Burke). Chapter 20. Quality of Life and Obesity. (M.R. Kinney). Chapter 21. Economic Impact of Obesity and its Cardiovascular Sequelae in Managed Care Settings. (K. McManus). Summary. (G.F. Fletcher). Index.
£106.35
McGraw-Hill Education / Medical Harrisons Principles of Internal Medicine Vol 1
Book Synopsis
£80.62
McGraw-Hill Companies Loose Leaf for Human Genetics
Book Synopsis
£140.40
Hay House Inc Body Belief
Book SynopsisImagine waking up feeling refreshed, strong, and vibrant, with your hormones in balance and your body nourished, stable, and supported on both the emotional and physical levels. For the millions who are grappling with rheumatoid arthritis, Hashimoto's thyroiditis, inflammatory bowel disease, type one diabetes, and numerous other autoimmune conditions, this vision seems so distant from the daily reality that it seems an impossibility. In spite of increasing knowledge and awareness, the causes and effects of autoimmune conditions are often misunderstood, and the connection between inner well-being and physical health is not fully explored.As an acupuncturist and herbalist with over 15 years of clinical experience, Aimee Raupp, M.S., L.Ac., has treated a variety of autoimmune conditions, as well as managed her own. Her Body Belief Plan bridges the gap between our internal and external healing to present a holistic and practical approach based on the core pillars of reconnecting to ourselvTrade Review"Aimee is a beacon of hope for all looking to improve their health and awaken their best life."— Deepak Chopra, M.D."Body Belief is must reading for every person who has ever felt sick and tired and doesn't know what's wrong. Rooted in compassion, rich with solid medical advice, and written by someone who has been there, Body Belief is a true treasure of life-changing information that will assist anyone in healing their body and their life."— Christiane Northrup, M.D., New York Times best-selling author of Women's Bodies, Women's Wisdom"Aimee Raupp is one of the most kind, generous, and talented healers. Her teachings have allowed me to transform the way I think about my body and my healing path. If you are longing to reawaken your health, Body Belief is the book you need and Aimee is the healer you want."— Gabrielle Bernstein, #1 New York Times best-selling author of The Universe Has Your Back"Aimee's teachings are filled with an immense amount of knowledge and research combined with real-life experience and a good dose of humor. In a masterful way, she equips her clients and followers with practical tools for achieving and maintaining optimal health and vitality despite the challenges of a modern lifestyle. She pours her wisdom and expertise and infuses her clients with the healing tools of self-love and self-acceptance."— Agapi Stassinopoulos, author of Wake Up to the Joy of You"Aimee Raupp understands that self-love can heal all parts of you—body and soul—and she can show you the path toward whole health in all its forms."— Rebekah Borucki, author of You Have 4 Minutes to Change Your Life"Aimee's message is a call to action for women of all ages to take control of their health through a path of self-love. The benefits transcend physical healing, aligning body, mind, and spirit to create optimal well-being and vitality."— Claudia Chan, author of This Is How We Rise
£16.14
John Wiley and Sons Ltd The Evaluation and Treatment of Syncope
Book SynopsisDesigned for the practitioner, this handbook provides an easy-to-read overview of how to evaluate and treat patients with a history of fainting. The 2nd Edition has been fully revised to contain all the latest information concerning diagnosis and treatment. It is based on the 2004 update of the ESC Guidelines on the Management of Syncope and offers up-to-date direction based on comprehensive analysis. All chapters share a consistent structure and are concise - only essential references are included. However, each chapter comes with suggestions for further reading and a comprehensive literature source is provided separately at the end of the book and divided into major interest areas. The ESC Education Series This book is part of the ESC Education Series. The series is designed to provide medical professionals with the latest information about the understanding, diagnosis and treatment of cardiovascular diseases. Where avTrade Review"This comprehensive tome is the most in depth presentation of the evaluation and treatment of patients with a history of fainting that I have come across.... You will learn a lot." (Cardiology News, June 2009)Table of ContentsSection one: Definition, pathophysiology, epidemiology. Chapter 1 Syncope: definition, classification, and multiple potential causes. Jean-Jacques Blanc, David G. Benditt. Chapter 2 Whatis syncope and whatis notsyncope: the importance of definitions. J. Gert van Dijk, Adam P. Fitzpatrick. Chapter 3 Pathophysiology and clinical presentation. Wouter Wieling, J. Gert van Dijk, Johannes J. van Lieshout, David G. Benditt. Chapter 4 Maintaining blood pressure while upright: physiology and potential for disturbances to cause syncope. Christopher J. Mathias. Chapter 5 Epidemiology and social costs of syncope. Rose Anne Kenny, Wishwa N. Kapoor. Section two: Syncope evaluation strategy. Chapter 6 Overview of recommended diagnostic strategies. Richard Sutton, Michele Brignole. Chapter 7 Initial evaluation of the syncope patient. Antonio Raviele, Paolo Alboni. Chapter 8 The role of the prepared questionnaire in initial evaluation of transient losses of consciousness. Anna Serletis, Robert S. Sheldon. Chapter 9 Who should be evaluated and treated in hospital, and who can be managed as an outpatient?. David G. Benditt. Chapter 10 Organizing management of syncope in the hospital and clinic (the syncope unit). Rose Anne Kenny, Michele Brignole. Chapter 11 Impact of syncope guidelines on clinical care. Michele Brignole. Section three: Specific diagnostic procedures. Chapter 12 Ambulatory electrocardiographic monitoring for evaluation of syncope. Adam P. Fitzpatrick, David G. Benditt. Chapter 13 Hemodynamic sensors: the future evaluation of syncope. David G. Benditt. Chapter 14 The basic autonomic assessment. Richard Sutton, David G. Benditt. Chapter 15 Electrophysiological testing. Fei Lü, Lennart Bergfeldt. Chapter 16 Miscellaneous diagnostic procedures: when are they indicated?. Lennart Bergfeldt, Piotr Kulakowski. Chapter 17 Neurologic diagnostic procedures in syncope. J. Gert van Dijk. Chapter 18 Contribution of psychiatric disorders to apparent syncope. George Theodorakis. Section four: Causes of syncope and syncope mimics, and treatment. Chapter 19 Who to treat. Michele Brignole, Rose Anne Kenny. Chapter 20 Specific causes of syncope: their evaluation and treatment strategies. Part 1 Neurally mediated reflex syncope. David G. Benditt, Jean-Jacques Blanc. Part 2 Orthostatic syncope. Angel Moya, Wouter Wieling. Part 3 Cardiac arrhythmias and conduction system disease as a primary cause of syncope. Angel Moya. Part 4 Structural cardiac and pulmonary causes of syncope. Jean-Jacques Blanc, Jan Janousek. Part 5 Cerebrovascular disorders as the primary cause of syncope. J. Gert van Dijk. Chapter 21 Syncope and other causes of transient loss of consciousness in children, teenagers, and adolescents. Wouter Wieling, Karin S. Ganzeboom, Jan Janousek. Chapter 22 Syncope in the older adult (including driving implications). Rose Anne Kenny, David G. Benditt. Chapter 23 Conditions that mimic syncope. J. Gert van Dijk. Section five: Selected references since 1990. Index
£81.65
£21.59
Arkansas Times Press The Public's Health: A Narrative History of
Book Synopsis
£999.99
John Wiley and Sons Ltd Annals Meeting Reports - Biomarkers in Nutrition,
Book SynopsisThis Annals volume presents three scholarly meeting reports: (1) Dissecting signaling and functions of adhesion G protein–coupled receptors; (2) Scientific considerations for complex drugs in light of established and emerging regulatory guidance; ; and (3) Fetal programming and environmental exposures: implications for prenatal care and preterm birth. G protein–coupled receptors (GPCRs) comprise an expanded superfamily of receptors in the human genome. Adhesion class G protein–coupled receptors (adhesion-GPCRs) form the second largest class of GPCRs. Despite the abundance, size, molecular structure, and functions in facilitating cell and matrix contacts in a variety of organ systems, adhesion-GPCRs are by far the most poorly understood GPCR class. The “6th International Adhesion-GPCR Workshop,” held at the Institute of Physiology of the University of Würzburg on September 6–8, 2012, assembled a majority of the investigators currently actively pursuing research on adhesion-GPCRs, including scientists from laboratories in Europe, the United States, and Asia. The meeting featured the nascent mechanistic understanding of the molecular events driving the signal transduction of adhesion-GPCRs, novel models to evaluate their functions, and evidence for their involvement in human disease. On March 9, 2012, the New York Academy of Sciences brought together experts representing a variety of perspectives—including academic, industrial, regulatory, as well as those from physicians and consumers—to discuss considerations for the non-biological complex drug (NBCD) regulatory approval pathway, given the emerging regulatory guidelines for biosimilars (follow-on biological complex drugs). Plenary sessions addressed the most recent regulatory developments, experimental design, interchangeability, and immunogenicity issues for follow-on versions of complex drugs from the perspective of key audiences, including industry, regulatory agencies, physicians, and consumers. This report summarizes various perspectives on NBCDs and the scientific and regulatory considerations associated with complex drug categories. Sponsored by the New York Academy of Sciences and Cincinnati Children’s Hospital Medical Center, with support from the National Institute of Environmental Health Sciences (NIEHS), the National Institute on Drug Abuse (NIDA), and Life Technologies, “Fetal Programming and Environmental Exposures: Implications for Prenatal Care and Preterm Birth” was held on June 11–12, 2012 at the New York Academy of Sciences in New York City. The meeting, comprising individual talks and panel discussions, highlighted basic, clinical, and translational research approaches, and highlighted the need for specialized testing of drugs, consumer products, and industrial chemicals, with a view to the unique impacts these can have during gestation. Speakers also discussed many other factors that affect prenatal development, from genetics to parental diet, revealing the extraordinary sensitivity of the developing fetus. NOTE: Annals volumes are available for sale as individual books or a s a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.Table of Contents1 Application of combined omics platforms to accelerate biomedical discovery in diabesityIrwin J. Kurland, Domenico Accili, Charles Burant, Steven M. Fischer, Barbara B. Kahn, Christopher B. Newgard, Suma Ramagiri, Gabriele V. Ronnett, john A. Ryals, Mark Sanders, Joe Shambaugh, John Shockcor, and Steven S. Gross 17 Prioritizing health disparities in medical education to improve careTemitope Awosogba, Joseph R. Betancourt, F. Garrett Conyers, Estela S. Estape, Fritz Francois, Sabrina J. Gard, Arthur Kaufman, Mitchell R. Lunn, Marc A. Nivet, Joel D. Oppenheim, Claire Pomeroy, and Howa Yeung 31 The paradox of overnutrition in aging and cognitionRoger A. Fielding, John Gunstad, Deborah R. Gustafson, Steven B. Heymsfield, John G. Kral, Lenore J. Launer, Josef Penninger, David I. W. Philips, and Nikolaos Scarmeas 45 Vitamin D: beyond boneSylvia Christakos, Martin Hewison, David G. Gardner, Carol L. Wagner, Igor N. Sergeev, Erica Rutten, Anastassios G. Pittas, Ricardo Boland, Luigi Ferrucci, and Daniel D. Bikle
£60.75
John Wiley and Sons Ltd Annals Meeting Reports - Diabetes and Oral
Book SynopsisThis volume presents reports from recent scientific meetings on topics in emerging fields: (1) Diabetes and Oral Disease: Implications for Health Professionals; (2) The New York Stem Cell Foundation: Sixth Annual Translational Stem Cell Research Conference; and (3) Chronic Inflammatory and Neuropathic Pain. "Diabetes and Oral Disease: Implications for Health Professionals" was a one-day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 at The New York Academy of Sciences in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the inter-professional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them and ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event. The New York Stem Cell Foundation’s "Sixth Annual Translational Stem Cell Research Conference" convened on October 11–12, 2011 at The Rockefeller University in New York City. Over 450 scientists, patient advocates, and stem cell research supporters from 14 countries registered for the conference. In addition to poster and platform presentations, the conference featured panels entitled "Road to the Clinic" and "The Future of Regenerative Medicine." Sponsored by The New York Academy of Sciences, MedImmune, and Grünenthal Gmbh, "Chronic Inflammatory and Neuropathic Pain" was a two-day conference June 2–3, 2011 at the New York Academy of Sciences in New York City. Leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies came together at this forum to address novel issues, current challenges, and future directions of basic research in pain and pre-clinical and clinical development of new therapies for chronic pain. Presentations examined recent therapeutic breakthroughs based on small molecules; the emerging role of biologics as potential new therapies; and current challenges and potential solutions for improved translation of new pain therapies following early target identification, pre-clinical modeling, and clinical development. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
£62.65
John Wiley and Sons Ltd Inositol Phospholipid Signaling in Physiology and
Book SynopsisA recent upsurge of research examining inositol phospholipids (IP)—membrane-bound species fundamental to cell signaling—continues underscore the role of this pathway in both normal and disease-associated cellular physiology. This volume includes a selection of cutting-edge, multidisciplinary reports borne out of the conference “Inositol Phospholipid Signaling in Physiology and Disease” held June 26–27, 2012 at the New York Academy of Sciences in New York City. Papers include important developments investigating IP signaling in immunology, cancer, inflammation, and metabolic disorders. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.Table of ContentsIntroduction to Inositol Phospholipid Signaling in Physiology and Disease v William G. Kerr and Sandra Fernandes Phosphoinositide 3-kinase and INPP4B in human breast cancer 1 Micka C. Bertucci and Christina A. Mitchell Role of SHIP1 in cancer and mucosal inflammation 6 Sandra Fernandes, Sonia Iyer, and William G. Kerr Role of SHIP1 in bone biology 11 Sonia Iyer, Bryan S. Margulies, and William G. Kerr Achieving cancer cell death with PI3K/mTOR-targeted therapies 15 Sung Su Yea and David A. Fruman Challenges in the clinical development of PI3K inhibitors 19 Cristian Massacesi, Emmanuelle di Tomaso, Nathalie Fretault, and Samit Hirawat Rules of engagement: distinct functions for the four class I PI3K catalytic isoforms in immunity 24 Klaus Okkenhaug Control of T cell tolerance by phosphatase and tensin homolog 27 Alexandria Huynh and Laurence A. Turka Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation 30 Shigenori Nagai, Yutaka Kurebayashi, and Shigeo Koyasu Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases 35 Srividya Sriskantharajah, Nicole Hamblin, Sally Worsley, Andrew R. Calver, Edith M. Hessel, and Augustin Amour Phosphoinositide 3-kinase gamma in T cell biology and disease therapy 40 Wai-Ping Fung-Leung Inhibition of phosphoinositide 3-kinase γ attenuates inflammation, obesity, and cardiovascular risk factors 44 Matthias P. Wymann and Giovanni Solinas Class III PI3K Vps34: essential roles in autophagy, endocytosis, and heart and liver function 48 Nadia Jaber and Wei-Xing Zong Inpp4b is a novel negative modulator of osteoclast differentiation and a prognostic locus for human osteoporosis 52 Jean Vacher
£104.50
Red Wheel/Weiser Your Nutrtion Solution to Inflammation: A
Book Synopsis
£12.34
Sounds True Inc Kicking Sick: Your Go-to Guide for Thriving with
Book SynopsisHas a chronic health issue taken over your life? More than half of us in the US are struggling with at least one. Amy Kurtz gets it. Starting in her mid-teens, she endured two perfect storms of illness that progressed into her twenties. It earned her the label "the sick chick"—and the shame, fear, isolation, and frustration that comes with it. She’s radically improved her health, and today she’s helping men and women of all ages live well regardless of their health situation. With honesty, humor, and empathy, Kicking Sick shows you how to jettison despair, tune in to your body and inner wisdom, take charge, and build an effective support circle of medical experts, friends, and family. Kicking Sick also brings you essential advice from Amy’s own A-team of experts—the ones crucial to her own turnaround: her personal physician Mark Hyman, gastroenterologist Gerard Mullin, endocrinologist Philip Felig, Crazy Sexy Cancer author Kris Carr, new thought leader Gabby Bernstein, and renowned yogi Elena Brower, plus many real life "glow warriors."
£15.19
American Society for Microbiology Outbreak: Cases in Real-World Microbiology
Book Synopsis
£999.99
Bull Publishing Company Vivre En Santé Avec Une Maladie Chronique: Pour
Book Synopsis
£38.91
Addicus Books Lung Cancer: From Diagnosis to Treatment
Book Synopsis
£16.16
Les Belles Lettres La Migraine, Biographie d'Une Maladie
Book Synopsis
£30.00
Librarie Philosophique J. Vrin Illness: The Cry of the Flesh
Book Synopsis
£23.00
Kohlhammer Psyche Und Soma: Erkenntnisse Und Implikationen
Book Synopsis
£37.97
Obelisco El Metodo Melt
Book Synopsis
£999.99
Obelisco Como Combatir la Artrosis
Book Synopsis
£999.99
L'Erma Di Bretschneider Emergenza Covid: Niguarda Case History:
Book Synopsis
£250.80
World Health Organization International Classification of Functioning,
Book Synopsis
£52.79
World Health Organization Good Laboratory Practice Training Manual for the
Book Synopsis
£43.30
World Health Organization The International Statistical Classification of
Book Synopsis
£31.90
World Health Organization Screening Donated Blood for
Book Synopsis
£32.77
World Health Organization Tuberculosis Prevalence Surveys: A Handbook
Book Synopsis
£42.00
World Health Organization Preventing Chronic Diseases: A Vital Investment
Book Synopsis
£34.36
World Health Organization Gender Women and Primary Health Care Renewal: A
Book Synopsis
£28.12
World Health Organization Working to Overcome the Global Impact of
Book Synopsis
£29.43
World Health Organization Global Report on Psoriasis
Book Synopsis
£22.00
World Health Organization Boîte À Outils Pour Une Gestion Vectorielle
Book Synopsis
£45.60
World Health Organization Control de Las Leishmaniasis: Informe de Una
Book Synopsis
£28.50
World Health Organization Reglamento Sanitario Internacional (2005)
Book Synopsis
£22.80
World Health Organization Global Status Report on Noncommunicable Diseases
Book Synopsis
£45.60
International Agency for Research on Cancer Ingested Nitrate and Nitrite and Cyanobacterial
Book Synopsis
£999.99
International Agency for Research on Cancer Malaria and some polyomaviruses [SV40, BK, JC and
Book Synopsis
£58.33
WHO Regional Office for South East Asia Framework for Implementing Integrated Vector
Book Synopsis
£12.00
WHO Regional Office for the Western Pacific Guidelines on verification of measles elimination
Book Synopsis
£23.06
Kapon Editions Encyclopaedia Autoanoson Nosimaton
Book Synopsis
£999.99
